SARS-CoV-2 systemic infection in a kidney transplant recipient: sequence analysis in clinical specimens.
COVID-19
/ virology
Feces
/ chemistry
Female
Graft Rejection
/ prevention & control
High-Throughput Nucleotide Sequencing
Humans
Immunosuppressive Agents
/ therapeutic use
Kidney Transplantation
Middle Aged
Mutation, Missense
/ genetics
Nasopharynx
/ chemistry
Phylogeny
Polyproteins
/ genetics
RNA, Viral
/ blood
SARS-CoV-2
/ genetics
Sequence Analysis, RNA
Viral Proteins
/ genetics
Journal
European review for medical and pharmacological sciences
ISSN: 2284-0729
Titre abrégé: Eur Rev Med Pharmacol Sci
Pays: Italy
ID NLM: 9717360
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
entrez:
4
12
2020
pubmed:
5
12
2020
medline:
22
12
2020
Statut:
ppublish
Résumé
Herein we report clinical and virological data in a patient with COVID-19 infection and a prior history of kidney transplantation who had a good clinical recovery despite systemic infection. Reverse transcriptase quantitative PCR analysis for the RdRp, N and E target genes detected viral RNA in different types of biological specimens. Whole viral genome sequences were obtained and analyzed from respiratory tract, feces and blood. Viral sequences showed high (~99.9%) homology with the Wuhan seafood market pneumonia virus. Phylogenetic analysis assigned of the SARS-CoV-2 strains to clade G. A rare variant in the orf1ab gene was present in both sequences, while a missense variant was detected only in viral RNA from stool. The evolution of the COVID-19 systemic infection in the patient presented here was favorable to the hypothesis that immunosuppressive therapy in organ transplant recipients might be involved in viral dissemination. A missense mutation was present in only one specimen from the same patient implying the occurrence of a mutational event in viral RNA, which is suggestive for the presence of an active virus, even though viral isolation is necessary to demonstrate infectivity.
Identifiants
pubmed: 33275263
doi: 10.26355/eurrev_202011_23850
pii:
doi:
Substances chimiques
Immunosuppressive Agents
0
ORF1ab polyprotein, SARS-CoV-2
0
Polyproteins
0
RNA, Viral
0
Viral Proteins
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM